Get the Stockscreener App
1.19
7.21%
0.08
After Hours:
1.19
Inovio Pharmaceuticals Inc Stock (INO) Forecast
The Inovio Pharmaceuticals Inc (INO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $24.92, representing a +1,994% increase from the current price of $1.19. The highest analyst price target is $27.64, and the lowest is $22.21.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month INO Price Target
Average 23.93
(+1,911% Upside)
Is Inovio Pharmaceuticals Inc (INO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 37.28 | Neutral |
| STOCH(9,6) | 12.75 | Buy |
| STOCHRSI(14) | 40.07 | Neutral |
| MACD(12,26) | -0.1547 | Sell |
| ADX(14) | 28.08 | Sell |
| William %R | -78.81 | Neutral |
| CCI(14) | -39.44 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.164
Buy
|
1.1994
Sell
|
| MA20 |
1.391
Sell
|
1.3298
Sell
|
| MA50 |
1.577
Sell
|
1.5195
Sell
|
| MA100 |
1.7156
Sell
|
1.6799
Sell
|
| MA200 |
1.8881
Sell
|
1.8302
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, INO could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 11 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on INO, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 37.28 indicates that INO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 12.75 indicates that INO is oversold. This indicates that INO price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 40.07 indicates that INO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 28.08 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -39.44 indicates that INO is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term INO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Inovio Pharmaceuticals Inc financial reports and earnings history, Inovio Pharmaceuticals Inc (INO) stock could reach $19.52 by 2030, $63.78 by 2040 and $89.98 by 2050. See the projected annual prices until 2050 of the Inovio Pharmaceuticals Inc stock below:
- Inovio Pharmaceuticals Inc (INO) is expected to reach an average price of $46.20 in 2035, with a high prediction of $46.21 and a low estimate of $45.68. This indicates an $3,782% rise from the last recorded price of $1.19.
- Inovio Pharmaceuticals Inc (INO) stock is projected to chart a bullish course in 2040, with an average price target of $63.68, representing an $5,251% surge from its current level. The forecast ranges from a conservative $63.09 to a sky-high $63.78.
- Our analysts predict Inovio Pharmaceuticals Inc (INO) to jump 6,457% by 2045, soaring from $77.62 to an average price of $78.03, potentially reaching $78.26. While $77.62 is the low estimate, the potential upside is significant.
- Inovio Pharmaceuticals Inc (INO) stock is expected to climb by 2050, reaching an average of $89.97, a $7,460% jump from its current level. However, a wide range of estimates exists, with high and low targets of $89.98 and $88.44, respectively, highlighting the market's uncertainty.
Inovio Pharmaceuticals Inc Stock (INO) Year by Year Forecast
Inovio Pharmaceuticals Inc Stock (INO) Price Forecast for 2026
The predicted value for Inovio Pharmaceuticals Inc (INO) in 2026 is set at an average of $26.40. Estimates vary from a peak of $32.57 to a trough of $20.23, indicating an +2,118% surge from the present price of $1.19.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2026 | $24.02 | $22.21 | $27.64 | +1,918% |
| June, 2026 | $22.85 | $22.73 | $24.38 | +1,821% |
| July, 2026 | $20.97 | $20.23 | $24.56 | +1,662% |
| August, 2026 | $23.74 | $21.02 | $24.97 | +1,895% |
| September, 2026 | $23.26 | $22.81 | $24.75 | +1,854% |
| October, 2026 | $24.28 | $22.66 | $24.58 | +1,940% |
| November, 2026 | $24.02 | $22.98 | $25.17 | +1,918% |
| December, 2026 | $22.83 | $22.81 | $24.37 | +1,818% |
Inovio Pharmaceuticals Inc Stock (INO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Inovio Pharmaceuticals Inc (INO) is $21.64, with a high forecast of $23.94 and a low forecast of $19.35. This indicates an +1,719% increase from the last price of $1.19.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $22.64 | $22.11 | $23.10 | +1,802% |
| February, 2027 | $23.46 | $22.57 | $23.73 | +1,872% |
| March, 2027 | $22.89 | $21.98 | $23.94 | +1,824% |
| April, 2027 | $21.37 | $21.03 | $22.93 | +1,696% |
| May, 2027 | $20.61 | $20.20 | $21.35 | +1,632% |
| June, 2027 | $20.24 | $19.78 | $20.79 | +1,601% |
| July, 2027 | $20.94 | $20.22 | $21.21 | +1,660% |
| August, 2027 | $20.45 | $20.40 | $21.47 | +1,619% |
| September, 2027 | $19.85 | $19.35 | $20.78 | +1,568% |
| October, 2027 | $19.69 | $19.47 | $19.92 | +1,555% |
| November, 2027 | $20.48 | $19.75 | $20.51 | +1,621% |
| December, 2027 | $21.23 | $20.20 | $21.30 | +1,684% |
Inovio Pharmaceuticals Inc Stock (INO) Price Forecast for 2028
In 2028, Inovio Pharmaceuticals Inc (INO) is projected to reach an average price of $21.43, with a high projection of $22.21 and a low estimate of $20.64. This indicates an +1,701% rise from the last price of $1.19.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $21.02 | $20.98 | $21.47 | +1,667% |
| February, 2028 | $20.77 | $20.64 | $21.21 | +1,646% |
| March, 2028 | $21.49 | $20.66 | $21.54 | +1,706% |
| April, 2028 | $21.57 | $21.40 | $22.11 | +1,712% |
| May, 2028 | $21.37 | $21.34 | $21.71 | +1,696% |
| June, 2028 | $21.76 | $21.29 | $22.00 | +1,728% |
| July, 2028 | $21.87 | $21.73 | $22.21 | +1,738% |
| August, 2028 | $21.70 | $21.65 | $21.95 | +1,724% |
| September, 2028 | $21.57 | $21.49 | $21.87 | +1,713% |
| October, 2028 | $21.84 | $21.56 | $21.91 | +1,735% |
| November, 2028 | $21.89 | $21.78 | $21.96 | +1,739% |
| December, 2028 | $21.98 | $21.88 | $22.01 | +1,747% |
Inovio Pharmaceuticals Inc Stock (INO) Price Forecast for 2029
The 2029 price forecast for Inovio Pharmaceuticals Inc Stock (INO) is $29.14 on average, with a high prediction of $38.88 and a low estimate of $19.39. This represents an +2,348% increase from the previous price of $1.19.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $22.35 | $22.02 | $22.37 | +1,778% |
| February, 2029 | $22.47 | $22.32 | $22.50 | +1,788% |
| March, 2029 | $22.67 | $22.50 | $22.73 | +1,805% |
| April, 2029 | $23.01 | $22.70 | $23.09 | +1,833% |
| May, 2029 | $23.13 | $22.97 | $23.19 | +1,843% |
| June, 2029 | $23.40 | $23.17 | $23.40 | +1,866% |
| July, 2029 | $23.74 | $23.43 | $23.76 | +1,895% |
| August, 2029 | $28.90 | $23.78 | $30.92 | +2,329% |
| September, 2029 | $31.61 | $28.35 | $32.30 | +2,556% |
| October, 2029 | $35.64 | $31.64 | $36.75 | +2,895% |
| November, 2029 | $33.93 | $32.60 | $38.88 | +2,751% |
| December, 2029 | $19.45 | $19.39 | $36.80 | +1,535% |
Inovio Pharmaceuticals Inc Stock (INO) Price Forecast for 2030
Inovio Pharmaceuticals Inc Stock (INO) is expected to reach an average price of $29.24 in 2030, with a high forecast of $40.15 and a low forecast of $18.33. This signifies an +2,357% surge from the last price of $1.19.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $18.71 | $18.33 | $19.52 | +1,473% |
| February, 2030 | $19.75 | $18.81 | $19.81 | +1,559% |
| March, 2030 | $19.82 | $19.38 | $20.06 | +1,565% |
| April, 2030 | $19.80 | $19.57 | $20.06 | +1,564% |
| May, 2030 | $20.26 | $19.79 | $20.69 | +1,603% |
| June, 2030 | $21.04 | $20.25 | $21.10 | +1,668% |
| July, 2030 | $21.71 | $20.88 | $21.86 | +1,725% |
| August, 2030 | $22.98 | $21.74 | $23.26 | +1,831% |
| September, 2030 | $23.27 | $22.97 | $23.63 | +1,855% |
| October, 2030 | $24.87 | $23.32 | $26.42 | +1,990% |
| November, 2030 | $28.43 | $24.38 | $40.15 | +2,289% |
| December, 2030 | $29.20 | $26.40 | $30.81 | +2,354% |
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):